全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

新型药物递送系统研究进展

DOI: 10.1360/052011-584, PP. 894-903

Keywords: 药物递送系统,脂质体,自组装药物传递系统,微球,渗透泵,缓控释微丸,干粉吸入剂

Full-Text   Cite this paper   Add to My Lib

Abstract:

药物递送系统系采用多学科的手段将药物有效地递送到目的部位,从而调节药物的代谢动力学、药效、毒性、免疫原性和生物识别等.与传统制剂相比,药物递送系统可以提高药物的稳定性,减少药物的降解;减轻药物的毒副作用;提高药物的生物利用度;维持稳定有效的血药浓度,避免血药浓度波动;可以提高靶区药物浓度.目前已发展建立了多种类型的新型药物递送系统,其研究投入和市场份额持续快速增长,推动着全球医药产业的发展.本文主要就军事医学科学院毒物药物研究所近年来研究内容:纳米靶向脂质体、新型纳米药物递送系统、长效缓释微球、口服缓控释制剂和干粉吸入制剂等研究进展作一综述.

References

[1]  1 梅兴国. 把握创新制剂推动我国药业发展新机遇. 国际药学研究杂志, 2010, 37: 89-91
[2]  2 梅兴国. 微载体药物递送系统. 武汉: 华中科技大学出版社, 2009. 128-184
[3]  3 Wang J Y, Wu Q F, Li J P, et al. Photo-sensitive liposomes: chemistry and application. Mini Rev Med Chem, 2010, 10: 172-181??
[4]  4 Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliver Rev, 2001, 53: 307-319??
[5]  5 Basel M T, Shrestha T B, Troyer D L, et al. Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomesusing triggered release. ACS Nano, 2011, 5: 2162-2175??
[6]  6 Hiraka K, Kanehisa M, Tamai M, et al. Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect. ColloidsSurf B Biointerfaces, 2008, 67: 54-58??
[7]  7 Kobatake E, Yamano R, Mie M. Targeted delivery using immunoliposomes with a lipid-modified antibody-binding protein. Appl BiochemBiotechnol, 2010, 163: 296-303
[8]  8 Li H, Lu Y, Piao L, et al. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined withreceptor modulation by all-trans retinoic acid. Int J Pharm, 2010, 402: 57-63??
[9]  9 Mendonca L S, Moreira J N, de Lima M C, et al. Co-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrinreceptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatment. Biotechnol Bioeng, 2010, 107: 884-893??
[10]  10 Bardonnet P L, Faivre V, Boullanger P, et al. Glycosylated liposomes against Helicobacter pylori: behavior in acidic conditions. BiochemBiophys Res Commun, 2009, 383: 48-53??
[11]  11 Yativin M B, Weinstein J N, Dennis W H, et al. Design of liposomes for enhanced local release of drugs by hyperthermia. Science, 1978,202: 1290-1293??
[12]  12 Koning G A, Eggermont A M M, Lindner L H, et al. Hyperthermia and thermosensitive liposomes for improved delivery ofchemotherapeutic drugs to solid tumors. Pharm Res, 2010, 27: 1750-1754??
[13]  13 Kono K, Ozawa T, Yoshida T, et al. Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specificchemotherapy. Biomaterials, 2010, 31: 7096-7105??
[14]  14 尤晓惠, 张慧, 潘见, 等. 紫杉醇热敏脂质体制备及抗肿瘤作用评价. 军事医学, 2011, 35: 219-222
[15]  15 杨美燕. 奥沙利铂长循环热敏脂质体研究. 北京: 中国人民解放军军事医学科学院. 2007
[16]  16 姜庆伟. 多西紫杉醇长循环热敏脂质体的研究. 北京: 中国人民解放军军事医学科学院. 2007
[17]  17 Suzuki R, Oda Y, Utoguchi N, et al. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- andmicrobubbles. J Control Release, 2011, 149: 36-41??
[18]  18 金义光. 自组装药物传递系统. 国际药学研究杂志, 2010, 37: 165-169
[19]  19 艾萍, 金义光, 王林. 药物传送中的纳米混悬液. 国外医学药学分册, 2005, 32: 61-63
[20]  20 金义光, 李广龙, 杜丽娜, 等. 核黄素衍生物高度分散制剂, 中国发明专利, 200810223485. 5, 2008
[21]  21 Astruc D. Dendrimers and nanosciences. C R Chimie, 2003, 6: 709-711??
[22]  22 金义光, 任霞, 杜丽娜, 等. pH 敏感树枝状聚合物药物载体. 中国发明专利, 200810223486. x. 2008
[23]  23 邢磊, 金义光, 杜丽娜. 多功能纳米载体. 国外医学药学分册, 2007, 34: 226-228
[24]  24 王辰允, 杜丽娜, 周文英, 等. 载阿霉素超声敏感纳米泡的制备与性质. 中国医院药学杂志, 2010, 30: 97-99
[25]  25 杨瑞, 梅丹宇, 杨媛, 等. 紫杉醇长循环肝靶向脂质体的制备. 军事医学科学院院刊, 2008, 32: 359-361
[26]  26 Tran V T, Benoti J P. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int JPharm, 2011, 407: 1-11
[27]  27 Freitas S, Merkle H P, Gander B. Microencapsulation by solvent extraction/ evaporation: reviewing the state of the art of microspherepreparation process technology. J Control Release, 2005, 102: 313-332??
[28]  28 艾国, 梅兴国. 缓释胸腺五肽微球的制备及体外释放的研究. 中国药学杂志, 2007, 42: 836-839
[29]  29 Li D C, Zhong X K, Zeng Z P, et al. Application of targeted drug delivery system in Chinese medicine. J Control Release, 2009, 138: 103-112??
[30]  30 卞丽红, 王洪权, 张明伟 等. PLGA 包裹的紫杉醇缓释微球的理化性质及抑瘤活性研究. 高技术通讯, 2005, 15: 57-60
[31]  31 王襄平, 梅兴国. 乳酸/羟基乙酸共聚物的分子量及其单位组成比例对利培酮微球性质的影响. 中国药房, 2007: 18: 38-41
[32]  32 Guan J, Zhou L, Pan Y, et al. A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivoevaluation. Pharm Res, 2010, 27: 105-114??
[33]  33 Zhang Z, Peng B, Yang X, et al. Design and evaluation of a novel floating osmotic pump system. J Pharm Pharm Sci, 2009, 12: 129-137
[34]  34 Guan J, Zhou L, Nie S, et al. A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation. Int J Pharm, 2010, 383: 30-36??
[35]  35 Tuntikulwattana S, Mitrevej A, Kerdcharoen T, et al. Development and optimization of micro/nanoporous osmotic pump tablets. AAPSPharmSciTech, 2010, 11: 924-935
[36]  36 Wei L, Li J, Guo L, et al. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm, 2007,33: 990-998??
[37]  37 颜琨, 梅兴国. 渗透泵给药系统设计原理、关键技术与发展动态. 国际药学研究杂志, 2010, 37: 92-97
[38]  38 高春生, 梅兴国. 微丸压片技术的研究进展. 中国药学杂志, 2006, 41: 163-166
[39]  39 黄健, 高春生, 单利, 等. 酒石酸美托洛尔缓释微丸的制备及处方因素考察. 中国新药杂志, 2006, 15: 1172-1175
[40]  40 Muschert S, Siepmann F, Leclercq B, et al. Simulated food effects on drug release from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Drug Dev Ind Pharm, 2010, 36: 173-179??
[41]  41 Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: Current perspectives. J Control Release, 2009, 134:74-80??
[42]  42 Mohamad A, Dashevsky A. In vitro and in vivo performance of a multiparticulate pulsatile drug delivery system. Drug Dev Ind Pharm, 2007,33: 113-119??
[43]  43 高春生, 单利, 黄健, 等. 盐酸二甲双胍肠溶微丸的成型工艺研究. 中国药学杂志, 2006, 41: 1872-1876
[44]  44 Karrout Y, Neut C, Wils D, et al. Novel polymeric film coatings for colon targeting: Drug release from coated pellets. Eur J Pharm Sci,2009, 37: 427-433??
[45]  45 梅兴国. 药物新剂型与制剂新技术. 北京: 化学工业出版社, 2007
[46]  46 陈新梅. 肺部给药研究新进展. 中国现代药物应用, 2010, 4: 224-226
[47]  47 Tsapis N, Bennett D, Jackson B, et al. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA,2002, 99: 12001-12005??
[48]  48 Zhang J, Wu L, Chan H K, et al. Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliver Rev, 2011, 63:441-455??
[49]  49 Behara S R B, Kippax P, Mcintosh M P, et al. structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisationand de-agglomeration behaviour under dynamic conditions. Eur J Pharm Sci, 2011, 42: 210-219??
[50]  50 Okamoto H, Danjo K. Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation. AdvancedDrug Delivery Reviews, 2008, 60: 433-446??
[51]  51 Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm, 2010, 392: 1-19??
[52]  52 Sebti, T H, Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm, 2006, 63:51-58??
[53]  53 Naikwade S R, Bajaj A N, Gurav P. Development of budesonide microparticles using spray-drying technology for pulmonary administration:design, characterization, in vitro evaluation, and in vivo efficacy study. AAPS Pharm Sci Tech, 2009, 10: 993-1012??
[54]  54 Klinger C, Müller B W, Steckel H. Insulin micro-and nanoparticles for pulmonary delivery. Int J Pharm, 2009, 377:173-179??
[55]  55 Zijlstra G S, Ponsioen B J, Hummel S A, et al. Formulation and process development of (recombinant human) deoxyribonuclease I as apowder for inhalation. Pharm Dev Technol, 2009, 14:358-368??
[56]  59 Newman S P. Dry powder inhalers for optimal drug delivery. Expert Opin Biol Ther, 2004, 4: 23-33??
[57]  56 Pilcer G, Vanderbist F, Amighi K. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties. JPharm Sci, 2009, 98: 1463-1475??
[58]  57 Saluja V, Amorij J P, Kapteyn J C, et al. A comparison between spray drying and spray freeze drying to produce an influenza subunitvaccine powder for inhalation. J Control Release, 2010, 144:127-133??
[59]  58 Chrystyn H. Closer to an ‘Ideal Inhaler’ with the easy haler: an innovative dry powder inhaler. Clin Drug Invest, 2006, 26: 175-183??
[60]  60 Hickey A J, Crowder T M. Next generation dry powder inhalation delivery systems. Lung Biol Health Dis, 2007, 221: 445-460
[61]  61 汤玥, 朱家壁, 陈西敬. 新型肺部给药系统-吸入粉雾剂. 药学学报, 2009, 44: 571-574
[62]  62 Islam N, Gladki E. Dry powder inhalers (DPIs)—a review of device reliability and innovation. Int J Pharm, 2008, 360: 1-11??

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133